Skip to content

Internet-based cognitive therapy for social anxiety disorder in Hong Kong

Internet-based cognitive therapy for social anxiety disorder in Hong Kong: a randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN11357117
Enrollment
40
Registered
2017-10-24
Start date
2017-11-01
Completion date
Unknown
Last updated
2022-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Social anxiety disorder Mental and Behavioural Disorders

Interventions

Participants will be recruited from the local population via advertisements in social and print media. Potential participants will be initially screened for eligibility using the social anxiety items

Sponsors

Chinese University of Hong Kong
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Meets DSM-5 criteria for SAD 2. Social anxiety problem has lasted at least six months 3. Participant considers SAD to be their main problem 4. Age 18-65 (inclusive) 5. Not currently taking psychotropic mediation, or on a stable dose for at least two months without improvement, and willing to remain at this dose throughout trial 6. Participant agrees not to start any other forms of treatment (medication or psychological) during the trial 7. Participant is a Chinese resident of Hong Kong, with sufficient proficiency in English to understand the treatment content 8. Regular access to an internet-connected computer or mobile device

Exclusion criteria

Exclusion criteria: 1. Current or past psychosis, bipolar disorder, or borderline personality disorder 2. Active suicidality 3. Dependence on alcohol or substances 4. Currently receiving psychological treatment 5. Having completed a course of CBT for social anxiety previously (defined as at least 5 sessions, and including an exposure component)

Design outcomes

Primary

MeasureTime frame
Severity of social anxiety, measured using the self-report version of the Liebowitz Social Anxiety Scale (Baker, Heinrichs, Kim, & Hofmann, 2002). The principal assessment points are pretreatment/prewait, midtreatment/midwait, posttreatment/postwait, and three month follow up.

Secondary

MeasureTime frame
1. Social anxiety, measured using: 1.1. Anxiety and Related Disorders Interview Schedule for DSM-5 (ADIS-5; Brown & Barlow, 2014). A clinical interview conducted by an independent assessor blind to treatment condition, at the posttreatment/postwait assessment point 1.2. Social Phobia Weekly Summary Scale (Clark, 1995) 1.3. Social Cognitions Questionnaire (Clark, 1995) 1.4. Social Phobia Inventory (Connor et al., 2000) 1.5. Social Behaviour Questionnaire (Clark, 1995) 1.6. Social Attitudes Questionnaire (Clark, 1995) 1.7. Fear of Negative Evaluation Scale (Watson & Friend, 1969) 1.8. Social Phobia Scale and Social Interaction Anxiety Scale (Mattick & Clarke, 1998) 1.9. Social Participation (Alden & Taylor, 2011) 1.10. Social Satisfaction (Alden & Taylor, 2011) 2.. Depression, measured using PHQ-9 (Kroencke, Spitzer, & Williams, 2001) 3. Generalised anxiety, measured using GAD-7 (Spitzer, Kroenke, Williams, & Löwe, 2006) 4. General functioning, measured using Work and Social Adjustment Scale (Mundt, Marks, Shear, & Greist, 2002) 5. Generalised learning, measured using Generalised Learning Questionnaire (in development) The principal assessment points are pretreatment/prewait, midtreatment/midwait, posttreatment/postwait, and three month follow up.

Countries

Hong Kong

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 18, 2026